The mission of the Cancer Epidemiology and Prevention Program is to reduce the burden of cancer. The strategy for successfully fulfilling this mission requires the research activities of the entire continuum of basic discovery, translational and clinical research. To achieve this goal, CEP members focus on these three specific aims:
- Discover and characterize novel risk and causative factors for cancer development. CEP members employ traditional epidemiological methods and state-of-the-art methodologies to assess the effect of both modifiable and unmodifiable factors and the gene-environment interactions on the development of cancers.
- Discover and evaluate novel approaches for prevention of cancer occurrence. CEP members employ randomized clinical trial study design to evaluate novel anti-cancer natural compounds and anti-cancer vaccine against the development and progression of common cancers.
- Discover and validate novel approaches for cancer screening and early detection to improve cancer outcomes and reduce cancer mortality. CEP members employ state-of-the-art technologies to discover, evaluate and validate biomarkers in peripheral biological samples and modern radiographic imaging techniques for screening and early detection of common cancers.